Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.
Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...
Giloy is renowned for its immune-boosting properties. A strong immune system can help the body fight off infections and ...
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...
Six men—Abolhassan Montazer, Akbar (Shahrokh) Daneshvarkar, Babak Alipour, Mohammad Taghavi Sangdehi, Pouya Ghobadi, and ...
The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...
Gout is a painful form of inflammatory arthritis ... and heart and kidney diseases that can increase the chances it will occur. The goal of treatment is to reduce levels of uric acid in the ...
Arthritis is a health condition that can cause swelling and tenderness in one or more joints whereas bursitis causes ...
PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a $77.5 million market cap company known for its focus on non-opioid pain management products, reported that the U.S. Food and Drug ...